BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $472,632 | +0.6% | 66,756 | 0.0% | 0.09% | -2.1% |
| Q2 2023 | $469,962 | -16.8% | 66,756 | -1.5% | 0.10% | -18.8% |
| Q1 2023 | $565,085 | -27.0% | 67,756 | +0.5% | 0.12% | -28.7% |
| Q4 2022 | $773,637 | -8.9% | 67,390 | 0.0% | 0.16% | -23.0% |
| Q3 2022 | $849,000 | +19.6% | 67,390 | +0.5% | 0.21% | +27.5% |
| Q2 2022 | $710,000 | -60.0% | 67,088 | -38.6% | 0.17% | -52.3% |
| Q1 2022 | $1,775,000 | +17.4% | 109,188 | 0.0% | 0.35% | +23.7% |
| Q4 2021 | $1,512,000 | -3.6% | 109,188 | 0.0% | 0.28% | -12.1% |
| Q3 2021 | $1,569,000 | -11.2% | 109,188 | -2.2% | 0.32% | -11.0% |
| Q2 2021 | $1,766,000 | +42.8% | 111,678 | -8.2% | 0.36% | +35.6% |
| Q1 2021 | $1,237,000 | +57.8% | 121,678 | +15.7% | 0.27% | +37.6% |
| Q4 2020 | $784,000 | – | 105,178 | +15.4% | 0.19% | – |
| Q3 2020 | $0 | -100.0% | 91,178 | +10.3% | 0.00% | -100.0% |
| Q2 2020 | $394,000 | +126.4% | 82,678 | -5.1% | 0.12% | +88.7% |
| Q1 2020 | $174,000 | +58.2% | 87,078 | +172.1% | 0.06% | +93.8% |
| Q4 2019 | $110,000 | – | 32,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |